P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
South Korea · Delayed Price · Currency is KRW 1,996.00
-74.00 (-3.57%)
At close: Apr 2, 2026
P&K Skin Research Center Market Cap
P&K Skin Research Center has a market cap or net worth of 57.65 billion as of April 2, 2026. Its market cap has decreased by -8.65% in one year.
Market Cap
57.65B
Enterprise Value
19.55B
Revenue
22.78B
Ranking
n/a
PE Ratio
12.32
Stock Price
1,996.00
Market Cap Chart
Since September 9, 2020, P&K Skin Research Center's market cap has decreased from 201.07B to 57.65B, a decrease of -71.33%. That is a compound annual growth rate of -20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 57.65B | -22.03% |
| Dec 30, 2025 | 73.94B | 21.62% |
| Dec 30, 2024 | 60.80B | -17.65% |
| Dec 28, 2023 | 73.83B | -18.95% |
| Dec 29, 2022 | 91.08B | -33.84% |
| Dec 30, 2021 | 137.67B | -19.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 575.56B |
| DreamCIS | 122.89B |
| HLB bioStep | 100.60B |
| WOOJUNG BIO | 45.52B |
| C&R Research | 44.37B |
| DT&CRO CO. | 42.95B |
| SLS BIO | 26.89B |
| BioInfra | 19.31B |